ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)

Fused Pyrrole/Pyridine Compound for Myt1 Inhibitor Cancer Treatment

The European Patent Office has published patent application EP4711364A1 for Pharmaengine, Inc., detailing a fused pyrrole or pyridine ring compound for use as a Myt1 inhibitor in cancer treatment. The publication includes the compound's formula, its use in a pharmaceutical composition, and a method for its preparation.

Nitrogen-Containing Heterocyclic Compound Patent Application

The European Patent Office has published patent application EP4711361A1 concerning a nitrogen-containing heterocyclic compound and its use, filed by Jiangsu Deyuan Pharmaceutical Co., Ltd. The application details compounds represented by formula (II), their stereoisomers, and pharmaceutically acceptable salts.

EPO Patent Application: Anti-c-Met Antibody Drug Conjugates

The European Patent Office has published a patent application (EP4656248A3) filed by AbbVie Manufacturing Management Unlimited Company for anti-c-Met antibody drug conjugates. The application details compositions and methods for using these conjugates, which are relevant to cancer treatments.

Shin-Etsu Chemical Patent for Resist Composition

The European Patent Office has published a patent application by Shin-Etsu Chemical Co., Ltd. for a novel onium salt, a chemically amplified positive resist composition, and a resist pattern forming process. The patent aims to improve resolution and reduce line edge roughness in pattern formation.

Pyridazinone Compounds as Thyroid Hormone Analogs Synthesis Methods

The European Patent Office has published a patent application detailing new synthesis methods for pyridazinone compounds, which act as thyroid hormone analogs. These methods aim to improve purity, yield, and scalability for large-scale preparation, and also describe morphic forms and a treatment method for thyroid hormone resistance.